Gene expression studies in multiple sclerosis

Current Genomics

Volumn 8, Issue 3, 2007, Pages 181-189

  Tajouri, Lotti ^a   Fernandez, Francesca ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 2; ANNEXIN; ANTIOXIDANT; BETA INTERFERON; BETA1A INTERFERON; GLATIRAMER; HEAT SHOCK PROTEIN; INTERFERON REGULATORY FACTOR; LEUKOTRIENE A4 HYDROLASE; MEVINOLIN; PROTEIN KINASE C BETA; TUMOR NECROSIS FACTOR ALPHA;

CAUCASIAN; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DISEASE MARKER; DNA MICROARRAY; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; ONSET AGE; PATHOGENESIS; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEX DIFFERENCE;

ANIMALIA; MUS;

EID: 34250184506     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920207780833829     Document Type: Review

References (77)

1. Bomprezzi, R., Ringner, M., Kim, S., Bittner, M.L., Khan, J., Chen, Y., Elkahloun, A., Yu, A., Bielekova, B., Meltzer, P.S., Martin, R., McFarland, H.F., Trent, J.M. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 2003, 12(17): 2191-9.
2. Balashov, K.E., Rottman, J.B., Weiner, H.L., Hancock, W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and EP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad Sci. USA 1999, 96(12): 6873-8.
3. Bardos, T., Kamath, R.V., Mikecz, K., Glant, T.T. Anti-inflammatory and chondroprotective effect of TSG-6 (tumour necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis. Am. J. Pathol. 2001, 159(5): 1711-21.
4. Bateman, A., Belcourt, D., Bennett, H., Lazure, C., Solomon, S. Granulins, a novel class of peptide from leukocytes. Biochem. Biophys. Res. Commun. 1990, 173(3): 1161-8.
5. Beall, S.S., Biddison, W.E., McFarlin, D.E., McFarland, H.F., Hood, L.E. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR V beta chain locus and HLA class II genes. J. Neuroimmunol. 1993, (1-2): 53-60.
6. Becker, K.G., Mattson, D.H., Powers, J.M., Gado, A.M., Biddison, W.E. Analysis of a sequenced cDNA library from multiple sclerosis lesions. J. Neuroimmunol. 1997, 77(1): 27-38.
7. Blanchon, L., Bocco, J.L., Gallot, D., Gachon, A.M., Lemery, D., Dechelotte, P., Dastugue, B., Sapin, V. Co-localization of KLF6 and KLF4 with pregnancy-specific glycoproteins during human placenta development Mech. Dev. 2001, 105(1-2): 185-9.
8. Blom, T., Franzen, A., Heinegard, D., Holmdahl, R. Comment on "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease". Science 2003, 299(5614): 1845.
9. Bomprezzi, R., Ringner, M., Kim, S., Bittner, M.L., Khan, J., Chen, Y., Elkahloun, A., Yu, A., Bielekova, B., Meltzer, P.S., Martin, R., McFarland, H.F., Trent, J.M. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol, Genet. 2003, 12(17): 2191-9.
10. Carmody, R.J., Hilliard, B., Maguschak, K., Chodosh, L.A., Chen, Y.H. Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J. Neuroimmunol. 2002, 133(1-2): 95-107.
11. Chabas, D., Baranzini, S.E., Mitchell, D., Bernard, C.C., Rittling, S.R., Denhardt, D.T., Sobel, R.A., Lock, C., Karpuj, M., Pedotti, R., Heller, R., Oksenberg, J.R., Steinman, L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.Science 2001, 294(5547): 1731-5.
12. Chan, A.C., Iwashima, M., Turck, C.W., Weiss, A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell. 1992, 71(4): 649-62.
13. Colognato, R., Slupsky, J.R., Jendrach, M., Burysek, L., Syrovets, T., Simmet, T. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood. 2003, 102(7): 2645-52.
14. Der, S.D., Zhou, A., Williams, B.R.G., Silverman, R.H. Identification of genes differentially regulated by interferon α, β or γ using the oligonucleotide arrays. PNAS. 1998, 95: 15623-15628.
15. Fife, B.T., Kennedy, K.J., Paniagua, M.C., Lukacs, N.W., Kunkel, S.L., Luster, A.D., Karpus, W.J. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2001, 166: 7617-7624.
16. Franciotta, D., Martino, G., Zardini, E., Furlan, R., Bergamaschi, R., Andreoni, L., Cosi, V. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J. Neuroimmunol. 2001, 115(1-2): 192-198.
17. GAMES and the Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. J. Neuroimmunol. 2003, 143: 39-46
18. Grewal, R.P., Morgan, T.E., Finch, C.E. C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis. Neurosci. Lett. 1999, 271(1): 65-7.
19. Hasko, G., Kuhel, D.G., Salzman, A.L., Szabo, C. ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages. Br. J. Pharmacol. 2000, 129(5): 909-14.
20. Hong, J., Zang, Y.C., Hutton, G., Rivera, V.M., Zhang, J.Z. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. J. Neuroimmunol. 2004, 152(1-2): 126-39.
21. Hu, W., Mathey, E., Hartung, H.P., Kieseier, B.C. Cyclooxygenases and prostaglandins in acute inflammatory demyelination of the peripheral nerve. Neurology 2003, 61(12): 1774-9.
22. Huang, D., Han, Y., Rani, M.R., Glabinski, A., Trebst, C., Sørensen, T., Tani, M., Wang, J., Chien, P., O'Bryan, S., Bielecki, B., Zhou, Z.L., Majumder, S., Ransohoff, R.M. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol. Rev. 2000, 177: 52-67.
23. Ibrahim, S.M., Mix, E., Bottcher, T., Koczan, D., Gold, R., Rolfs, A., Thiesen, H.J. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 2001, 124(Pt 10): 1927-38.
24. Iglesias, A.H., Camelo, S., Hwang, D., Villanueva, R., Stephanopoulos, G., Dangond, F. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells. J. Neuroimmunol. 2004, 150(1-2): 163-77.
25. Jordon. Real-time detection of PCR products and microbiology. Life Science 2000, 61-66.
26. Karp, C.L., Biron, C.A., Irani, D.N. Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol. Today. 2000, 21(1): 24-8.
27. Kelleher, K.L., Leck, K.J., Hendry, I.A., Matthaei, K.I. A one-step quantitative reverse transcription polymerase chain reaction procedure. Brain Res. Protoc. 2001, 6: 100-107.
28. Kermode, A.G., Thompson, A.J., Tofts, P., MacManus, D.G., Kendall, B.E., Kingsley, D.P., Moseley, I.F., Rudge, P., McDonald, W.I., Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990, 113: 1477-1489.
29. Klegeris, A., Bissonnette, C.J., Dorovini-Zis, K., McGeer, P.L. Expression of complement messenger RNAs by human endothelial cells. Brain Res. 2000, 871(1): 1-6.
30. Koike, F., Satoh, J., Miyake, S., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura K., Yokoyama, K., Ota, K., Kanda, T., Fukazawa, T., Yamamura, T. Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis. J. Neuroimmunol. 2003, 139(1-2):109-18.
31. Kurland, L.T. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. Am. J. Hygiene 1952, 55: 457-476.
32. Lee, S.T., Nicholls, R.D., Schnur, R.E., Guida, L.C., Lu-Kuo, J., Spinner, N.B., Zackai, E.H., Spritz, R.A. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2). Hum. Mol. Genet. 1994, 3(11): 2047-51.
33. Liau, L.M., Lallone, R.L., Seitz, R.S., Buznikov, A., Gregg, J.P., Kornblum, H.I., Nelson, S.F., Bronstein, J.M. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Res. 2000, 60(5): 1353-60.
34. Lindberg, R.L., De Groot, C.J., Certa, U., Ravid, R., Hoffmann, F., Kappos, L., Leppert, D. Multiple sclerosis as a generalized CNS disease-comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J. Neuroimmunol. 2004, 152(1-2): 154-67.
35. Livak, K.J., Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta CT)) Method. Methods 2001, 25: 402-408.
36. Liu, N., Lamerdin, J.E., Tucker, J.D., Zhou, Z.Q., Walter, C.A., Albala, J.S., Busch, D.B., Thompson, L.H. The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells. Proc. Natl. Acad. Sci. USA 1997, 94(17): 9232-7.
37. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S.J., Oksenberg, J.R., Raine, C.S., Heller, R., Steinman, L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8(5): 500-8.
38. Loetscher, M., Gerber, B., Loetscher, P., Jones, S.A., Piali, L., Clark-Lewis, I., Baggiolini, M., Moser, B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 1996, 184(3): 963-9.
39. Loetscher, M., Loetscher, P., Brass, N., Meese, E., Moser, B. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol. 1998, 28(11): 3696-705.
40. Lumsden, C.E. The neropathology of multiple sclerosis. Handb. Clin. Neurol. 1970, 9: 217
41. Luster, A.D., Unkeless, J.C., Ravetch, J.V. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985, 315(6021): 672-6.
42. Muller, K., Bendtzen, K. 1,25-dihydroxyvitamin D3 as a natural regulator of human immune functions. J. Investig. Dermatol. Symp. Proc. 1996, 1: 68-71.
43. Murga, M., Fernandez-Capetillo, O., Field, S.J., Moreno, B., Borlado, L.R., Fujiwara, Y., Balomenos, D., Vicario, A., Carrera, A.C., Orkin, S.H., Greenberg, M.E., Zubiaga, A.M. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 2001, 15(6): 959-70.
44. Mycko, M.P., Papoian, R., Boschert, U., Raine, C.S., Selmaj, K.W. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain 2003, 126(Pt 5): 1048-57.
45. Mycko, M.P., Cwiklinska, H., Szymanski, J., Szymanska, B., Kudla, G., Kilianek, L., Odyniec, A., Brosnan, C.F., Selmaj, K.W. Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II. J. Immunol. 2004, 172(1):202-13.
46. Paintlia, A.S., Paintlia, M.K., Singh, A.K., Stanislaus, R., Gilg, A.G., Barbosa, E., Singh, I. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin. J. Neurosci. Res. 2004, 77(1): 63-81.
47. Pericak-Vance, M.A., Rimmler, J.B., Haines, J.L,. Garcia, M.E., Oksenberg, J.R., Barcellos, L.F., Lincoln, R., Hauser, S.L., Cournu-Rebeix, I., Azoulay-Cayla, A., Lyon-Caen, O., Fontaine, B., Duhamel, E., Coppin, H., Brassat, D., Roth, M.P., Clanet, M., Alizadeh, M., Yaouanq, J., Quelvennec, E., Semana, G., Edan, G., Babron, M.C., Genin, E., Clerget-Darpoux, F. Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study. Neurogenetics 2004, 5(1): 45-8.
48. Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S.X., Lonning, P.E., Borresen-Dale, A.L., Brown, P.O., Botstein, D. Molecular portraits of human breast tumours. Nature 2000, 406: 747-752.
49. Rajan, A.J., Gao, Y.L., Raine, C.S., Brosnan, C.F. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 1996, 157(2): 941-9.
50. Ramanathan, M., Weinstock-Guttman, B., Nguyen, L.T., Badgett, D., Miller, C., Patrick, K., Brownscheidle, C., Jacobs, L. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 2001, 116(2): 213-9.
51. Ransohoff, R.M., Bacon, K.B. Chemokine receptor antagonism as a new therapy for multiple sclerosis. Expert Opin. Investig. Drugs. 2000, 9: 1079-1097.
52. Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R.A., Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 2002, 16(2): 245-56.
53. Ridley, A. Molecular switches in metastasis. Nature 2000, 406: 466-467.
54. Sadovnick, A.D., Armstrong, H., Rice, G.P., Bulman, D., Hashimoto, L., Paty, D.W., Hashimoto, S.A., Warren, S., Hader, W., Murray, T.J. A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 1993, 33: 281-285.
55. Satoh, J., Paty, D.W., Kim, S.U. Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 incultured fetal human astrocytes. Neurology 1995, 45(2):367-73.
56. Satoh, J., Nakanishi, M., Koike, F., Miyake, S., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura, K., Yokoyama, K., Ota, K., Kanda, T., Fukazawa, T., Yamamura, T. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis. 2005, 18(3): 537-50.
57. Satoh, J., Nakanishi, M., Koike, F., Onoue, H., Aranami, T., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura K., Yokoyama, K., Ota, K., Saito, T., Ohta, M., Miyake, S., Kanda, T., Fukazawa, T., Yamamura, T. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J. Neuroimmunol. 2006, 174(1-2): 108-18.
58. Satoh, J., Nanri, Y., Tabunoki, H., Yamamura, T. Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis. BMC Neurol. 2006, 6: 18.
59. Shak, S., Goldstein, I.M. Omega-oxidation is the major pathway for the catabolism of leucotriene B4 in human polymorphonuclear leukocytes. J. Biol. Chem. 1984, 259(16): 10181-7.
60. Simpson, J.E., Newcombe, J., Cuzner, M.L., Woodroofe, M.N. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 2000, 26(2): 133-42.
61. Sorensen, T.L., Trebst, C., Kivisakk, P., Klaege, K.L., Majmudar, A., Ravid. Multiple sclerosis: a study of CXCL10 and CXCR3 colocalization in the inflamed central nervous system. J. Neuroimmunol. 2002, 127: 59-68.
62. Sturzebecher, S., Wandinger, K.P., Rosenwald, A., Sathyamoorthy, M., Tzou, A., Mattar, P., Frank, J.A., Staudt, L., Martin, R., McFarland, H.F. Expression profiling identifies responder and nonresponder phenotypes to interferon-beta in multiple sclerosis. Brain 2003, 126(Pt 6): 1419-29.
63. Tajouri, L., Mellick, A.S., Ashton, K.J., Tannenberg, A.E., Nagra, R.M., Tourtellotte, W.W., Griffiths, L.R. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res. Mol. Brain Res. 2003, 119(2): 170-83.
64. Tanaka, T.S., Jaradat, S.A., Lim, M.K., Kargul, G.J., Wang, X., Grahovac, M.J., Pantano, S., Sano, Y., Piao, Y., Nagaraja, R., Do,i H., Wood, W.H. 3rd, Becker, K.G., Ko, M.S. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc. Natl. Acad. Sci. USA 2000, 97: 9127-9132.
65. Tani, M., Glabinski, A.R., Tuohy, V.K., Stoler, M.H., Estes, M.L., Ransohoff, R.M. In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 1996, 148: 889-896
66. Tsutsui, S., Schuermann, J., Noorbakhsh, F., Henry, S., Yong, V.W., Winston, B.W., Warren, K., Power, C. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci. 2004, 24(6): 1521-9.
67. Vukusic, S., Hutchinson, M., Hours, M., Moreau, T., Cortinovis-Tourniaire, P., Adeleine, P., Confavreux, C. The Pregnancy In Multiple Sclerosis Group; Pregnancy In Multiple Sclerosis Group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004, 127(Pt 6): 1353-60.
68. Wandinger, K.P., Sturzebecher, C.S., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L.M., McFarland, H.F., Martin, R. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol. 2001, 50(3): 349-57.
69. Wang, X., Chen, M., Wandinger, K.P., Williams, G., Dhib-Jalbut, S. IFN-beta-1b inhibits IL-12 production in peripheral blood monomiclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis. J. Immunol. 2000, 165(1): 548-57.
70. Weinshenker, B.G. Natural history of multiple sclerosis. Ann. Neurol. 1994, 36: S6-11.
71. Weinstock-Guttman, B., Badgett, D., Patrick, K., Hartrich, L., Santos, R., Hall, D., Baier, M., Feichter, J., Ramanathan, M. Genomic effects of IFN-beta in multiple sclerosis patients. J. Immunol. 2003, 171(5): 2694-702.
72. Whitney, L.W., Becker, K.G., Tresser, N.J., Caballero-Ramos, C.I., Munson, P.J., Prabhu, V.V., Trent, J.M., McFarland, H.F., Biddison, W.E. Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 1999, 46(3): 425-8.
73. Whitney, L.W., Ludwin, S.K., McFarland, H.F., Biddison, W.E. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol. 2001, 121(1-2): 40-8.
74. Wingerchuk, D., Liu, Q., Sobell, J., Sommer, S., Weinshenker, B.G. A population-based case-control study of the tumour necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology 1997, 49(2): 626-8.
75. Yin, J.L., Shackel, N.A., Zekry, A., McGuinness, P.H., Richards, C., Putten, K.V., McCaughan, G.W., Eris, J.M., Bishop, G.A. Realtime reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol. Cell Biol. 2001, 79: 213-221.
76. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., Shimizu, T. A G-protein-coupled receptor for leucotriene B4 that mediates chemotaxis. Nature 1997, 387(6633): 620-4.
77. Young, V.W., Chabot, S., Stuve, O., Williams, G. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 1998, 51: 682-689.